Ibuprofen With or Without Acetaminophen for Low Back Pain
Study Details
Study Description
Brief Summary
This is a randomized clinical trial comparing two interventions for acute low back pain:
-
Ibuprofen + acetaminophen
-
Ibuprofen + placebo
Participants will include patients who present to an emergency room for management of low back pain. Medication will be dispensed to participants at the time of emergency room discharge. Data will be collected from participants by telephone for 1 week.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 3 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Acetaminophen Acetaminophen 500-1000mg every 6 hours for 7 days Participants in this arm will also receive ibuprofen 600mg every 6 hours for 7 days and an educational intervention. |
Drug: Acetaminophen
Acetaminophen 500-1000mg every 6 hours
Drug: Ibuprofen 600 mg
Ibuprofen 600mg every 6 hours
Behavioral: Educational intervention
Research personnel will provide each patient with a 15-minute educational intervention. This will be based on NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases) Handout on Health: Back Pain information webpage (available at http://www.niams.nih.gov/Health_Info/Back_Pain/default.asp)
|
Active Comparator: Placebo Placebo Participants in this arm will also receive ibuprofen 600mg every 6 hours for 7 days and an educational intervention. |
Drug: Ibuprofen 600 mg
Ibuprofen 600mg every 6 hours
Behavioral: Educational intervention
Research personnel will provide each patient with a 15-minute educational intervention. This will be based on NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases) Handout on Health: Back Pain information webpage (available at http://www.niams.nih.gov/Health_Info/Back_Pain/default.asp)
Drug: Placebo oral capsule
To match acetaminophen, patients will take one or two capsules every 6 hours
|
Outcome Measures
Primary Outcome Measures
- Change in Functional Impairment as Measured by the Roland Morris Disability Questionnaire [Baseline and one week after discharge from emergency department]
The Roland Morris Disability Questionnaire (RMDQ) is a 24 item instrument that evaluates the impact of low back pain on one's daily life. It is most sensitive for patients with mild to moderate disability due to acute, sub-acute or chronic low back pain. Each question can be answered as either a "yes" or "no". The score ranges from 0 to 24 where a higher score reflects greater impairment and, therefore, worsening in the quality of life. The change in RMDQ is obtained by subtracting the RMDQ score at one week after discharge from the baseline score. The calculated mean and associated confidence interval values have been verified by staff statisticians.
Secondary Outcome Measures
- Number of Participants With Moderate or Severe Pain, as Measured on an Ordinal Scale [7 days after discharge from emergency department]
Data collected by telephone questionnaire. Participants asked to assess intensity of low back pain over the previous 24 hours, using a four point ordinal scale: severe, moderate, mild, or none.
- Number of Participants Who Required Analgesic Medication for Low Back Pain Within the Previous 24 Hours. [7 days after discharge from emergency department]
Telephone questionnaire is used to assess number of patients needing any analgesic or low back pain medication within the previous 24 hours.
Eligibility Criteria
Criteria
Inclusion Criteria:
Present to emergency room primary for management of LBP, defined as pain originating between the lower border of the scapulae and the upper gluteal folds. Flank pain, that is pain originating from tissues lateral to the paraspinal muscles, will not be included.
-
Musculoskeletal etiology of low back. Patients with non-musculoskeletal etiologies such as urinary tract infection, ovarian cysts, or influenza like illness will be excluded. The primary clinical diagnosis, at the conclusion of the emergency room visit, must be a diagnosis consistent with non-traumatic, non-radicular, musculoskeletal low back pain.
-
Patient is to be discharged home.
-
Age 18-69
-
Non-radicular pain. Patients will be excluded if the pain radiates below the gluteal folds in a radicular pattern.
-
Pain duration <2 weeks (336 hours).
-
Prior to the acute attack of LBP, back pain cannot occur more frequently than once per month.
-
Non-traumatic LBP: no substantial and direct trauma to the back within the previous month
-
Functionally impairing back pain: A baseline score of > 5 on the Roland-Morris Disability Questionnaire
Exclusion Criteria:
-
Not available for follow-up
-
Pregnant
-
Chronic pain syndrome defined as use of any analgesic medication on a daily or near-daily basis
-
Allergic to or intolerant of investigational medications
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Montefiore Medical Center | Bronx | New York | United States | 10467 |
Sponsors and Collaborators
- Montefiore Medical Center
Investigators
- Principal Investigator: Benjamin W Friedman, MD, MS, Montefiore Medical Center
Study Documents (Full-Text)
More Information
Publications
None provided.- 2018-9182
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | Acetaminophen | Placebo |
---|---|---|
Arm/Group Description | Acetaminophen 500-1000mg every 6 hours for 7 days Participants in this arm will also receive ibuprofen 600mg every 6 hours for 7 days and an educational intervention. Acetaminophen: Acetaminophen 500-1000mg every 6 hours Ibuprofen 600 mg: Ibuprofen 600mg every 6 hours Educational intervention: Research personnel will provide each patient with a 15-minute educational intervention. This will be based on NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases) Handout on Health: Back Pain information webpage (available at http://www.niams.nih.gov/Health_Info/Back_Pain/default.asp) | Placebo Participants in this arm will also receive ibuprofen 600mg every 6 hours for 7 days and an educational intervention. Ibuprofen 600 mg: Ibuprofen 600mg every 6 hours Educational intervention: Research personnel will provide each patient with a 15-minute educational intervention. This will be based on NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases) Handout on Health: Back Pain information webpage (available at http://www.niams.nih.gov/Health_Info/Back_Pain/default.asp) Placebo oral capsule: To match acetaminophen, patients will take one or two capsules every 6 hours |
Period Title: Overall Study | ||
STARTED | 60 | 60 |
COMPLETED | 57 | 53 |
NOT COMPLETED | 3 | 7 |
Baseline Characteristics
Arm/Group Title | Acetaminophen | Placebo | Total |
---|---|---|---|
Arm/Group Description | Acetaminophen 500-1000mg every 6 hours for 7 days Participants in this arm will also receive ibuprofen 600mg every 6 hours for 7 days and an educational intervention. Acetaminophen: Acetaminophen 500-1000mg every 6 hours Ibuprofen 600 mg: Ibuprofen 600mg every 6 hours Educational intervention: Research personnel will provide each patient with a 15-minute educational intervention. This will be based on NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases) Handout on Health: Back Pain information webpage (available at http://www.niams.nih.gov/Health_Info/Back_Pain/default.asp) | Placebo Participants in this arm will also receive ibuprofen 600mg every 6 hours for 7 days and an educational intervention. Ibuprofen 600 mg: Ibuprofen 600mg every 6 hours Educational intervention: Research personnel will provide each patient with a 15-minute educational intervention. This will be based on NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases) Handout on Health: Back Pain information webpage (available at http://www.niams.nih.gov/Health_Info/Back_Pain/default.asp) Placebo oral capsule: To match acetaminophen, patients will take one or two capsules every 6 hours | Total of all reporting groups |
Overall Participants | 60 | 60 | 120 |
Age (years) [Mean (Standard Deviation) ] | |||
Mean (Standard Deviation) [years] |
41
(12)
|
41
(13)
|
41
(12)
|
Sex: Female, Male (Count of Participants) | |||
Female |
29
48.3%
|
28
46.7%
|
57
47.5%
|
Male |
31
51.7%
|
32
53.3%
|
63
52.5%
|
Race and Ethnicity Not Collected (Count of Participants) | |||
Count of Participants [Participants] |
0
0%
|
||
Region of Enrollment (participants) [Number] | |||
United States |
60
100%
|
60
100%
|
120
100%
|
Duration of low back pain (hours) [Median (Inter-Quartile Range) ] | |||
Median (Inter-Quartile Range) [hours] |
48
|
48
|
48
|
Outcome Measures
Title | Change in Functional Impairment as Measured by the Roland Morris Disability Questionnaire |
---|---|
Description | The Roland Morris Disability Questionnaire (RMDQ) is a 24 item instrument that evaluates the impact of low back pain on one's daily life. It is most sensitive for patients with mild to moderate disability due to acute, sub-acute or chronic low back pain. Each question can be answered as either a "yes" or "no". The score ranges from 0 to 24 where a higher score reflects greater impairment and, therefore, worsening in the quality of life. The change in RMDQ is obtained by subtracting the RMDQ score at one week after discharge from the baseline score. The calculated mean and associated confidence interval values have been verified by staff statisticians. |
Time Frame | Baseline and one week after discharge from emergency department |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Acetaminophen | Placebo |
---|---|---|
Arm/Group Description | Acetaminophen 500-1000mg every 6 hours for 7 days Participants in this arm will also receive ibuprofen 600mg every 6 hours for 7 days and an educational intervention. Acetaminophen: Acetaminophen 500-1000mg every 6 hours Ibuprofen 600 mg: Ibuprofen 600mg every 6 hours Educational intervention: Research personnel will provide each patient with a 15-minute educational intervention. This will be based on NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases) Handout on Health: Back Pain information webpage (available at http://www.niams.nih.gov/Health_Info/Back_Pain/default.asp) | Placebo Participants in this arm will also receive ibuprofen 600mg every 6 hours for 7 days and an educational intervention. Ibuprofen 600 mg: Ibuprofen 600mg every 6 hours Educational intervention: Research personnel will provide each patient with a 15-minute educational intervention. This will be based on NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases) Handout on Health: Back Pain information webpage (available at http://www.niams.nih.gov/Health_Info/Back_Pain/default.asp) Placebo oral capsule: To match acetaminophen, patients will take one or two capsules every 6 hours |
Measure Participants | 57 | 53 |
Mean (Standard Deviation) [units on a scale] |
11.1
(10.7)
|
11.9
(9.7)
|
Title | Number of Participants With Moderate or Severe Pain, as Measured on an Ordinal Scale |
---|---|
Description | Data collected by telephone questionnaire. Participants asked to assess intensity of low back pain over the previous 24 hours, using a four point ordinal scale: severe, moderate, mild, or none. |
Time Frame | 7 days after discharge from emergency department |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Acetaminophen | Placebo |
---|---|---|
Arm/Group Description | Acetaminophen 500-1000mg every 6 hours for 7 days Participants in this arm will also receive ibuprofen 600mg every 6 hours for 7 days and an educational intervention. Acetaminophen: Acetaminophen 500-1000mg every 6 hours Ibuprofen 600 mg: Ibuprofen 600mg every 6 hours Educational intervention: Research personnel will provide each patient with a 15-minute educational intervention. This will be based on NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases) Handout on Health: Back Pain information webpage (available at http://www.niams.nih.gov/Health_Info/Back_Pain/default.asp) | Placebo Participants in this arm will also receive ibuprofen 600mg every 6 hours for 7 days and an educational intervention. Ibuprofen 600 mg: Ibuprofen 600mg every 6 hours Educational intervention: Research personnel will provide each patient with a 15-minute educational intervention. This will be based on NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases) Handout on Health: Back Pain information webpage (available at http://www.niams.nih.gov/Health_Info/Back_Pain/default.asp) Placebo oral capsule: To match acetaminophen, patients will take one or two capsules every 6 hours |
Measure Participants | 57 | 53 |
Count of Participants [Participants] |
16
26.7%
|
15
25%
|
Title | Number of Participants Who Required Analgesic Medication for Low Back Pain Within the Previous 24 Hours. |
---|---|
Description | Telephone questionnaire is used to assess number of patients needing any analgesic or low back pain medication within the previous 24 hours. |
Time Frame | 7 days after discharge from emergency department |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Acetaminophen | Placebo |
---|---|---|
Arm/Group Description | Acetaminophen 500-1000mg every 6 hours for 7 days Participants in this arm will also receive ibuprofen 600mg every 6 hours for 7 days and an educational intervention. Acetaminophen: Acetaminophen 500-1000mg every 6 hours Ibuprofen 600 mg: Ibuprofen 600mg every 6 hours Educational intervention: Research personnel will provide each patient with a 15-minute educational intervention. This will be based on NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases) Handout on Health: Back Pain information webpage (available at http://www.niams.nih.gov/Health_Info/Back_Pain/default.asp) | Placebo Participants in this arm will also receive ibuprofen 600mg every 6 hours for 7 days and an educational intervention. Ibuprofen 600 mg: Ibuprofen 600mg every 6 hours Educational intervention: Research personnel will provide each patient with a 15-minute educational intervention. This will be based on NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases) Handout on Health: Back Pain information webpage (available at http://www.niams.nih.gov/Health_Info/Back_Pain/default.asp) Placebo oral capsule: To match acetaminophen, patients will take one or two capsules every 6 hours |
Measure Participants | 57 | 52 |
Count of Participants [Participants] |
36
60%
|
32
53.3%
|
Adverse Events
Time Frame | 48 hours | |||
---|---|---|---|---|
Adverse Event Reporting Description | ||||
Arm/Group Title | Acetaminophen | Placebo | ||
Arm/Group Description | Acetaminophen 500-1000mg every 6 hours for 7 days Participants in this arm will also receive ibuprofen 600mg every 6 hours for 7 days and an educational intervention. Acetaminophen: Acetaminophen 500-1000mg every 6 hours Ibuprofen 600 mg: Ibuprofen 600mg every 6 hours Educational intervention: Research personnel will provide each patient with a 15-minute educational intervention. This will be based on NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases) Handout on Health: Back Pain information webpage (available at http://www.niams.nih.gov/Health_Info/Back_Pain/default.asp) | Placebo Participants in this arm will also receive ibuprofen 600mg every 6 hours for 7 days and an educational intervention. Ibuprofen 600 mg: Ibuprofen 600mg every 6 hours Educational intervention: Research personnel will provide each patient with a 15-minute educational intervention. This will be based on NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases) Handout on Health: Back Pain information webpage (available at http://www.niams.nih.gov/Health_Info/Back_Pain/default.asp) Placebo oral capsule: To match acetaminophen, patients will take one or two capsules every 6 hours | ||
All Cause Mortality |
||||
Acetaminophen | Placebo | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/60 (0%) | 0/60 (0%) | ||
Serious Adverse Events |
||||
Acetaminophen | Placebo | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/60 (0%) | 0/60 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
Acetaminophen | Placebo | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 5/60 (8.3%) | 2/60 (3.3%) | ||
Gastrointestinal disorders | ||||
Diarrhea | 3/60 (5%) | 1/60 (1.7%) | ||
Nervous system disorders | ||||
Drowsiness | 2/60 (3.3%) | 1/60 (1.7%) |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Benjamin Friedman |
---|---|
Organization | Montefiore |
Phone | 718-920-6626 |
befriedm@montefiore.org |
- 2018-9182